Pilates With Diaphragmatic Breathing in Sedentary Women (PDB-Pilates)
11 juni 2026 bijgewerkt door: Veli Volkan Gürses, Bandırma Onyedi Eylül University
Effects of Pilates Combined With Diaphragmatic Breathing on Cardiopulmonary Markers in Sedentary Women: A Randomized Controlled Trial
This randomized controlled trial evaluated whether adding diaphragmatic breathing exercises to an eight-week supervised Pilates program improves pulmonary function, resting heart rate, and core endurance in sedentary women aged 35 years and older.
Participants were randomized to Pilates combined with diaphragmatic breathing or Pilates alone.
Both groups trained three times per week for eight weeks.
Studie Overzicht
Toestand
Voltooid
Interventie / Behandeling
Gedetailleerde beschrijving
Participants were sedentary women aged 35 years and older who had not participated in regular structured exercise during the previous six months.
Participants were randomly assigned in a 1:1 ratio to either Pilates combined with diaphragmatic breathing exercises or Pilates alone.
Both groups completed supervised exercise sessions three times per week for eight weeks.
Each session lasted approximately 60 minutes and included warm-up, main Pilates exercises, and cool-down.
The experimental group additionally performed structured diaphragmatic and abdominal breathing exercises integrated into the Pilates sessions.
Pulmonary function, cardiovascular parameters, functional performance, anthropometry, and echocardiographic safety parameters were assessed at baseline and after the intervention.
Studietype
Ingrijpend
Inschrijving (Werkelijk)
24
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studie Locaties
-
-
Bandırma
-
Balıkesir, Bandırma, Turkije (Türkiye), 10010
- Bandirma Onyedi Eylul University, Faculty of Medicine
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Ja
Beschrijving
Inclusion Criteria:
- Female participants aged 35 years or older
- Sedentary status, defined as no regular structured exercise participation during the previous six months
- Non-smoker
- No diagnosed cardiovascular, pulmonary, or musculoskeletal disorder
- Not using medications known to influence cardiopulmonary function
- Provided written informed consent
Exclusion Criteria:
- Pregnancy
- Recent surgery or injury
- Participation in another structured exercise program during the study period
- Any cardiovascular, pulmonary, or musculoskeletal condition that could affect safe participation
- Use of medication known to influence cardiopulmonary function
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Pilates Exercise Diaphragmatic Breathing Exercise
Participants completed an eight-week supervised Pilates program combined with structured diaphragmatic and abdominal breathing exercises.
Sessions were performed three times per week and lasted approximately 60 minutes.
|
Participants completed a supervised mat-based Pilates exercise program three times per week for eight weeks.
Each session lasted approximately 60 minutes and included a warm-up phase, a main Pilates exercise component targeting core stability, flexibility, postural alignment, and muscular endurance, and a cool-down phase.
Participants performed structured diaphragmatic and abdominal breathing exercises integrated into the Pilates sessions.
The breathing protocol included slow nasal inhalation, controlled oral exhalation, abdominal expansion, segmental thoracic breathing, and guided breathing rhythm during selected Pilates exercises.
|
|
Actieve vergelijker: Pilates Alone
Participants completed the same eight-week supervised Pilates program without specific diaphragmatic breathing instruction.
Sessions were performed three times per week and lasted approximately 60 minutes.
|
Participants completed a supervised mat-based Pilates exercise program three times per week for eight weeks.
Each session lasted approximately 60 minutes and included a warm-up phase, a main Pilates exercise component targeting core stability, flexibility, postural alignment, and muscular endurance, and a cool-down phase.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Peak Expiratory Flow
Tijdsspanne: Baseline and after 8 weeks
|
Peak expiratory flow was assessed by spirometry.
The change from baseline to the end of the eight-week intervention was evaluated.
|
Baseline and after 8 weeks
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Forced Vital Capacity
Tijdsspanne: Baseline and after 8 weeks
|
Forced vital capacity was assessed by spirometry.
|
Baseline and after 8 weeks
|
|
Change in Forced Expiratory Volume in One Second
Tijdsspanne: Baseline and after 8 weeks
|
FEV1 was assessed by spirometry.
|
Baseline and after 8 weeks
|
|
Change in FEV1/FVC Ratio
Tijdsspanne: Baseline and after 8 weeks
|
The FEV1/FVC ratio was calculated from spirometric measurements.
|
Baseline and after 8 weeks
|
|
Change in Resting Heart Rate
Tijdsspanne: Baseline and after 8 weeks
|
Resting heart rate was measured after at least 10 minutes of seated rest.
|
Baseline and after 8 weeks
|
|
Change in Plank Test Performance
Tijdsspanne: Baseline and after 8 weeks
|
Core muscular endurance was assessed using the prone plank test, recorded in seconds.
|
Baseline and after 8 weeks
|
|
Change in Echocardiographic Safety Parameters
Tijdsspanne: Baseline and after 8 weeks
|
Echocardiographic parameters including ejection fraction, ventricular dimensions, wall thickness, and flow velocities were evaluated for safety monitoring.
|
Baseline and after 8 weeks
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Onderzoekers
- Hoofdonderzoeker: DUYGU DURMAZ, PHD, Bandirma Onyedi Eylul University, Faculty of Medicine
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Werkelijk)
3 juni 2025
Primaire voltooiing (Werkelijk)
5 september 2025
Studie voltooiing (Werkelijk)
7 oktober 2025
Studieregistratiedata
Eerst ingediend
11 juni 2026
Eerst ingediend dat voldeed aan de QC-criteria
11 juni 2026
Eerst geplaatst (Werkelijk)
16 juni 2026
Updates van studierecords
Laatste update geplaatst (Werkelijk)
16 juni 2026
Laatste update ingediend die voldeed aan QC-criteria
11 juni 2026
Laatst geverifieerd
1 juni 2026
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- BANU-PILATES-DB-2025-76
- Other Identifier (Andere identificatie: 2025-76)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
JA
Beschrijving IPD-plan
De-identified individual participant data underlying the results reported in the article will be made available upon reasonable request.
IPD-tijdsbestek voor delen
Beginning after publication and available for 5 years.
IPD-toegangscriteria voor delen
Data will be shared with researchers who submit a methodologically sound proposal and obtain approval from the corresponding author and, if required, the institutional ethics committee.
IPD delen Ondersteunend informatietype
- LEERPROTOCOOL
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .